EVFM · Evofem Biosciences, Inc.
$0.01
+0.00 (+7.04%)
At close · Aug 18
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has concluded that these circumstances and the uncertainties associated with the Company's ability to obtain additional equity or debt financing on terms that are favorable to the Company, or at all, and otherwise succeed in its future operations raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$954,216
Shares
132.53M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Saundra Pelletier | — | $827,799 |
| Justin J. File | Chief Financial Officer | $767,453 |
| Alexander A. Fitzpatrick | General Counsel | $537,638 |
| Katherine Atkinson | Chief Commercial Officer | $492,738 |
| Russ Barrans | Chief Commercial Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Justin J. File | Chief Financial Officer | $1,042,172 |
| Russ Barrans | Chief Commercial Officer | $1,039,450 |
| Saundra Pelletier | — | $1,004,004 |
| Alexander A. Fitzpatrick | General Counsel | $929,740 |
| Katherine Atkinson | Chief Commercial Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Saundra Pelletier | — | $3,144,344 |
| Justin J. File | Chief Financial Officer | $2,014,035 |
| Russ Barrans | Chief Commercial Officer | $1,927,426 |
| Alexander A. Fitzpatrick | General Counsel | $1,677,582 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Saundra Pelletier | Chief Executive Officer | $2,803,983 |
| Russell Barrans | Chief Commercial Officer | $1,372,818 |
| Russ Barrans | Chief Commercial Officer | $1,372,818 |
| Justin J. File | Chief Financial Officer | $1,183,010 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Saundra Pelletier | Chief Executive Officer | $8,298,122 |
| Justin J. File | Chief Financial Officer | $3,299,756 |
| Russell Barrans | Chief Commercial Officer | $2,016,508 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ivy Zhang | Chief Financial Officer and Secretary | Appointed | 2023-04-14 |
| Saundra Pelletier | Secretary | Resigned | 2023-04-14 |
| Albert Altro | interim Chief Financial Officer | Terminated | 2023-04-14 |
| Saundra Pelletier | Secretary | Appointed | 2023-04-10 |
| Katherine Atkinson | Chief Commercial Officer | Terminated | 2023-03-21 |
| Albert Altro | interim Chief Financial Officer | Appointed | 2023-03-09 |
| Justin J. File | Chief Financial Officer | Resigned | 2023-03-09 |
| Jenny Yip | member of the Company's board of directors | Resigned | 2023-02-16 |
| Justin J. File | Secretary | Appointed | 2022-12-21 |
| Alexander A. Fitzpatrick | General Counsel and Secretary | Resigned | 2022-10-14 |
| Jenny Yip | Class III director | Appointed | 2022-08-03 |
| William Hall, Ph.D., M.D. | member of the Board | Resigned | 2021-11-19 |